Schneyer Mark C.

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
15
Insider Sells Sum
$1.4M

Insider Activity of Schneyer Mark C.

According to the SEC Form 4 filings, Schneyer Mark C., being in a position of

  1. EVP, CHIEF FINANCIAL OFFICER at ACADIA Pharmaceuticals Inc.,
    оver the last 12 months, has bought 0 shares, and sold 33392 shares for $559,784,
    over all time since 2022-02-23, has bought 0 shares, and sold 68483 shares for $1.4M.

The largest sale of all time was on 2023-05-17 and amounted to 15310 shares of ACADIA Pharmaceuticals Inc. for $344,475.

Biography of Schneyer Mark C.

No biography is available at this moment.

2024-11-19SaleACADIA Pharmaceuticals Inc.
ACAD
EVP, CHIEF FINANCIAL OFFICER
10,259
0.0064%
$16.81$172,454-3.45%
2024-08-19SaleACADIA Pharmaceuticals Inc.
ACAD
EVP, CHIEF FINANCIAL OFFICER
9,733
0.0057%
$15.28$148,720+2.86%
2024-06-10SaleACADIA Pharmaceuticals Inc.
ACAD
EVP, CHIEF FINANCIAL OFFICER
975
0.0006%
$14.79$14,420+8.47%
2024-05-02SaleACADIA Pharmaceuticals Inc.
ACAD
EVP, CHIEF FINANCIAL OFFICER
3,503
0.0021%
$16.94$59,341-7.62%
2024-04-08SaleACADIA Pharmaceuticals Inc.
ACAD
EVP, CHIEF FINANCIAL OFFICER
2,716
0.0017%
$17.87$48,535-9.33%
2024-03-27SaleACADIA Pharmaceuticals Inc.
ACAD
EVP, CHIEF FINANCIAL OFFICER
5,434
0.0032%
$17.90$97,269-10.77%
2024-02-26SaleACADIA Pharmaceuticals Inc.
ACAD
EVP, CHIEF FINANCIAL OFFICER
772
0.0004%
$24.67$19,045-36.81%
2023-11-20SaleACADIA Pharmaceuticals Inc.
ACAD
EVP, Chief Financial Officer
5,108
0.0031%
$22.64$115,645-22.36%
2023-08-21SaleACADIA Pharmaceuticals Inc.
ACAD
EVP, Chief Financial Officer
10,000
0.0059%
$29.00$289,970-26.52%
2023-06-08SaleACADIA Pharmaceuticals Inc.
ACAD
EVP, Chief Financial Officer
974
0.0006%
$25.02$24,369-5.06%
2023-05-17SaleACADIA Pharmaceuticals Inc.
ACAD
EVP, Chief Financial Officer
15,310
0.0094%
$22.50$344,475+6.13%
2023-04-06SaleACADIA Pharmaceuticals Inc.
ACAD
EVP, Chief Financial Officer
1,916
0.0012%
$18.16$34,795+31.17%
2023-02-24SaleACADIA Pharmaceuticals Inc.
ACAD
EVP, Chief Financial Officer
577
0.0004%
$18.78$10,836+26.85%
2022-06-08SaleACADIA Pharmaceuticals Inc.
ACAD
EVP, Chief Financial Officer
653
0.0004%
$17.91$11,695-5.85%
2022-02-23SaleACADIA Pharmaceuticals Inc.
ACAD
Chief Financial Officer
553
0.0003%
$23.80$13,161-32%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.